ACUTE LEUKEMIA BEFORE AND AFTER CHEMOTHERAPY WITH RESPECT TO LIVER FUNCTION TESTS

Authors

  • Mohammed Saad M Alqahtan1 , Abdullah Hamed A Al-Onzai2 Abdulelah Mohammed Salem Albuayjan3 and Bandar Mahmoud Alasmar Alonazi4 Author

Keywords:

Alanine Transaminase (ALT), Aspartate Transaminase (AST), Bilirubin, Acute Leukemia , before and after Chemotherapy, Liver Function Tests and chemotherapy.

Abstract

Background: Chemotherapeutic agents can cause hypersensitivity reactions or direct hepatic toxicity, while altered liver function can change drug metabolism and increase the risk of non-hepatic toxicity.

Methodology: Serum total bilirubin was measured with the DMSO method, while serum AST and ALT were measured using the kinetic method before and after chemotherapy doses.

Results: The results found that chemotherapy-induced hepatotoxicity in patients with acute leukaemia.

Conclusions: This study concluded that chemotherapeutic drugs cause an increase in serum total bilirubin, ALT, and AST during the treatment of acute leukaemia. Liver function tests should be performed on a regular basis while treating leukaemia patients.

Downloads

Published

2019-05-22

Issue

Section

Articles